| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 20 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 18 |
| NetGPI | no | yes: 0, no: 19 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005759 | mitochondrial matrix | 5 | 20 |
| GO:0031974 | membrane-enclosed lumen | 2 | 20 |
| GO:0043233 | organelle lumen | 3 | 20 |
| GO:0070013 | intracellular organelle lumen | 4 | 20 |
| GO:0110165 | cellular anatomical entity | 1 | 20 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 180 | 184 | PF00656 | 0.572 |
| CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.343 |
| CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.265 |
| CLV_NRD_NRD_1 | 244 | 246 | PF00675 | 0.358 |
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.553 |
| CLV_PCSK_FUR_1 | 124 | 128 | PF00082 | 0.249 |
| CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.369 |
| CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.326 |
| CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.552 |
| CLV_PCSK_PC1ET2_1 | 126 | 128 | PF00082 | 0.249 |
| CLV_PCSK_PC7_1 | 26 | 32 | PF00082 | 0.643 |
| CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.488 |
| DEG_APCC_DBOX_1 | 5 | 13 | PF00400 | 0.427 |
| DOC_PP4_FxxP_1 | 51 | 54 | PF00568 | 0.481 |
| DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.514 |
| DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.667 |
| DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.509 |
| LIG_14-3-3_CterR_2 | 245 | 249 | PF00244 | 0.558 |
| LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.424 |
| LIG_eIF4E_1 | 116 | 122 | PF01652 | 0.487 |
| LIG_FHA_1 | 18 | 24 | PF00498 | 0.518 |
| LIG_FHA_2 | 136 | 142 | PF00498 | 0.481 |
| LIG_FHA_2 | 37 | 43 | PF00498 | 0.467 |
| LIG_FHA_2 | 91 | 97 | PF00498 | 0.498 |
| LIG_LIR_Apic_2 | 190 | 195 | PF02991 | 0.480 |
| LIG_LIR_Apic_2 | 50 | 54 | PF02991 | 0.484 |
| LIG_LIR_Gen_1 | 113 | 123 | PF02991 | 0.467 |
| LIG_LIR_Gen_1 | 70 | 81 | PF02991 | 0.395 |
| LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.495 |
| LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.533 |
| LIG_SH2_CRK | 13 | 17 | PF00017 | 0.547 |
| LIG_SH2_CRK | 192 | 196 | PF00017 | 0.499 |
| LIG_SH2_GRB2like | 116 | 119 | PF00017 | 0.558 |
| LIG_SH2_GRB2like | 237 | 240 | PF00017 | 0.487 |
| LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.483 |
| LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.455 |
| LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.475 |
| LIG_SH3_3 | 50 | 56 | PF00018 | 0.468 |
| LIG_SUMO_SIM_anti_2 | 141 | 147 | PF11976 | 0.470 |
| LIG_SUMO_SIM_par_1 | 90 | 97 | PF11976 | 0.421 |
| LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.558 |
| LIG_WW_3 | 52 | 56 | PF00397 | 0.385 |
| MOD_CK1_1 | 136 | 142 | PF00069 | 0.435 |
| MOD_CK2_1 | 16 | 22 | PF00069 | 0.519 |
| MOD_CK2_1 | 36 | 42 | PF00069 | 0.462 |
| MOD_CK2_1 | 90 | 96 | PF00069 | 0.454 |
| MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.308 |
| MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.309 |
| MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.396 |
| MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.624 |
| MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.558 |
| MOD_GSK3_1 | 147 | 154 | PF00069 | 0.574 |
| MOD_GSK3_1 | 90 | 97 | PF00069 | 0.530 |
| MOD_LATS_1 | 185 | 191 | PF00433 | 0.366 |
| MOD_NEK2_1 | 133 | 138 | PF00069 | 0.482 |
| MOD_NEK2_1 | 16 | 21 | PF00069 | 0.464 |
| MOD_NEK2_1 | 177 | 182 | PF00069 | 0.559 |
| MOD_NEK2_1 | 94 | 99 | PF00069 | 0.587 |
| MOD_NEK2_2 | 36 | 41 | PF00069 | 0.564 |
| MOD_Plk_1 | 133 | 139 | PF00069 | 0.526 |
| MOD_Plk_2-3 | 202 | 208 | PF00069 | 0.487 |
| TRG_DiLeu_BaEn_4 | 112 | 118 | PF01217 | 0.441 |
| TRG_DiLeu_BaLyEn_6 | 239 | 244 | PF01217 | 0.487 |
| TRG_ENDOCYTIC_2 | 116 | 119 | PF00928 | 0.482 |
| TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.418 |
| TRG_ER_diArg_1 | 30 | 33 | PF00400 | 0.546 |
| TRG_NES_CRM1_1 | 141 | 155 | PF08389 | 0.528 |
| TRG_NLS_MonoCore_2 | 123 | 128 | PF00514 | 0.470 |
| TRG_NLS_MonoExtC_3 | 124 | 129 | PF00514 | 0.470 |
| TRG_NLS_MonoExtN_4 | 124 | 129 | PF00514 | 0.470 |
| TRG_Pf-PMV_PEXEL_1 | 33 | 37 | PF00026 | 0.569 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P990 | Leptomonas seymouri | 27% | 100% |
| A0A0N1HS24 | Leptomonas seymouri | 71% | 98% |
| A0A0S4ITN8 | Bodo saltans | 31% | 100% |
| A0A1X0NTH7 | Trypanosomatidae | 66% | 95% |
| A0A1X0P207 | Trypanosomatidae | 30% | 100% |
| A0A3Q8IBW7 | Leishmania donovani | 28% | 100% |
| A0A3Q8IFM4 | Leishmania donovani | 92% | 98% |
| A4HCI6 | Leishmania braziliensis | 81% | 100% |
| A4HI52 | Leishmania braziliensis | 28% | 89% |
| A4I007 | Leishmania infantum | 92% | 98% |
| A4I5C8 | Leishmania infantum | 28% | 100% |
| C9ZQR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
| C9ZSQ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 96% |
| C9ZU92 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 67% |
| E9B0M6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
| Q4Q7K6 | Leishmania major | 28% | 91% |
| Q4QBJ9 | Leishmania major | 89% | 100% |
| V5BDB3 | Trypanosoma cruzi | 65% | 95% |